On a Friday call with analysts, Sanofi execs pointed to an efficacy edge for its preventive and stressed that more ...

Sanofi is nearing a sale of a 50% stake in its consumer unit, valued at 16 billion euros in total, to boost clinical trials ...

Sanofi reported third-quarter earnings and sales that beat analysts' expectations, boosted by earlier-than-anticipated deliveries of flu and respiratory syncytial virus vaccines and growing demand for ...

Since 1995, Consumer Cellular has been bridging the gap between older adults and the latest in cellular technology. As of this writing, it’s also one of the most affordable cellular carriers, with ...

Consumer Reports is helping to make sure that the food you eat is safe and healthy, and that you have the information you need to make the best food choices. Consumer Reports' tests have found that ...

French Economy, Finance and Industry Minister Antoine Armand attends a joint press conference on the government's role ...

(Sebastian Guth, 10/16) Emmanuel Macron’s administration has agreed to take a 1%-2% stake in Sanofi SA’s consumer-health unit Opella to sugar the pill of a US private equity takeover, seen as a ...

Yet another therapy with FDA accelerated approval suffers a setback; Sage’s tough year continues; Sanofi drops $326 million ...

The US buyout firm is pairing with the French pharma giant to buy out its consumer unit. Success here requires much more than ...

PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its ...

Recent health news highlights include a CDC team assessing bird flu in Washington state farm workers, CVS's leadership change ...